HEM Hemosense

HemoSense, Inc. (AMEX:HEM) today announced that it will release financial results for the three months and year ended September 30, 2006 after market close on Monday, November 20, 2006. HemoSense management will host an investment community conference call beginning at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss those results and answer questions. Individuals interested in participating in the conference call may do so by dialing (877) 815-7177 for domestic callers, or (706) 634-1178 for international callers. Those interested in listening to the conference call live via the Internet may do so by visiting the Investors section of the company�s Web site at www.hemosense.com. A telephone replay will be available for 48 hours following the conclusion of the call by dialing (800) 642-1687 for domestic callers, or (706) 645-9291 for international callers, and entering reservation code 9167445. A webcast replay will be available for 30 days by visiting the Investors section on the HemoSense Web site. About HemoSense HemoSense develops, manufactures and markets easy-to-use, handheld blood coagulation systems for monitoring patients taking warfarin. The HemoSense INRatio� system, used by healthcare professionals and patients themselves, consists of a small monitor and disposable test strips. It provides accurate and convenient measurement of blood clotting time, or PT/INR values. Routine measurements of PT/INR are necessary for the safe and effective management of the patient�s warfarin dosing. INRatio is sold in the United States and internationally. For more information, visit www.hemosense.com. HemoSense, Inc. (AMEX:HEM) today announced that it will release financial results for the three months and year ended September 30, 2006 after market close on Monday, November 20, 2006. HemoSense management will host an investment community conference call beginning at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss those results and answer questions. Individuals interested in participating in the conference call may do so by dialing (877) 815-7177 for domestic callers, or (706) 634-1178 for international callers. Those interested in listening to the conference call live via the Internet may do so by visiting the Investors section of the company's Web site at www.hemosense.com. A telephone replay will be available for 48 hours following the conclusion of the call by dialing (800) 642-1687 for domestic callers, or (706) 645-9291 for international callers, and entering reservation code 9167445. A webcast replay will be available for 30 days by visiting the Investors section on the HemoSense Web site. About HemoSense HemoSense develops, manufactures and markets easy-to-use, handheld blood coagulation systems for monitoring patients taking warfarin. The HemoSense INRatio(R) system, used by healthcare professionals and patients themselves, consists of a small monitor and disposable test strips. It provides accurate and convenient measurement of blood clotting time, or PT/INR values. Routine measurements of PT/INR are necessary for the safe and effective management of the patient's warfarin dosing. INRatio is sold in the United States and internationally. For more information, visit www.hemosense.com.